Pelagos Pharmaceuticals, Inc.
Houston, TX
- UEI
- F4N3K1KN7GL6
- CAGE
- 8T0J1
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3737 Buffalo Speedway #1750, Houston, TX 77098, USA
- Website
- pelagospharma.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Developing novel REV-ERB agonists for the treatment of neuroinflammation in alzheimer's disease - alzheimer's disease… | National Institute on Aging (NIH) | $1,007,151 |
Quick answers
Is Pelagos Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Pelagos Pharmaceuticals, Inc.'s SAM.gov registration is active through March 7, 2027.
What is Pelagos Pharmaceuticals, Inc.'s most recent federal award?
Pelagos Pharmaceuticals, Inc.'s most recent federal grant award is Developing novel REV-ERB agonists for the treatment of neuroinflammation in alzheimer's disease - alzheimer's disease… (R41AG079778), from National Institute on Aging (NIH), on August 17, 2022.
On GovTribe
See Pelagos Pharmaceuticals, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors